Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Aging (Phase 1)
Anemia, Sickle Cell (Phase 2)
Blood Pressure (Phase 4)
Cardiovascular Diseases (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Endothelial Cells (Phase 1)
Exercise (Phase 1)
Heart Failure (Phase 2)
Heart Failure, Diastolic (Phase 2)
Heart Failure, Systolic (Phase 2)
Hypercholesterolemia (Phase 1)
Hypertension (Phase 2)
Hypertension, Pregnancy-Induced (Early Phase 1)
Hypertension, Pulmonary (Phase 1/Phase 2)
Inflammation (Phase 1)
Ischemic Stroke (Phase 2)
Mucositis (Phase 2)
Muscular Dystrophies (Early Phase 1)
Nitric Oxide (Phase 1)
Nutritional Physiological Phenomena (Phase 4)
Peripheral Arterial Disease (Phase 2)
Peripheral Vascular Diseases (Phase 1)
Postmenopause (Phase 2)
Postoperative Complications (Phase 2)
Pregnancy (Phase 1)
Renal Insufficiency, Chronic (Phase 4)
Respiratory Insufficiency (Phase 1)
Sarcopenia (Phase 1)
Sports Medicine (Phase 4)
Stroke (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
